Search

Home > GRACEcast Lung Cancer Video > Is the Survival Benefit with Avastin Added to Chemotherapy Enough to Change the Standard of Care in Mesothelioma?
Podcast: GRACEcast Lung Cancer Video
Episode:

Is the Survival Benefit with Avastin Added to Chemotherapy Enough to Change the Standard of Care in Mesothelioma?
Category: Science & Medicine
Duration: 00:02:01
Publish Date: 2015-10-30 14:00:00
Description:

Drs. Ben Solomon, Leora Horn, & Jack West discuss highlights of a French randomized trial that demonstrated a significant survival benefit from addition of Avastin (bevacizumab) to cisplatin/Alimta in patients with malignant pleural mesothelioma.
Total Play: 0